Dechra Veterinary Products

Following the acquisition of VetXX in January 2008 Dechra Veterinary Products now operates in ten countries across Europe.

• Denmark
• Finland
• France
• Ireland
• Netherlands
• Norway
• Portugal
• Spain
• Sweden
• UK

The company's product portfolio is focused on providing therapeutic solutions for the care of companion animals. The key areas of expertise span dermatology, endocrinology, equine medicine, ophthalmology and critical care. The leading branded pharmaceuticals for companion animals include Vetoryl® Capsules, for the treatment of canine hyperadrenocorticism (Cushing's syndrome); Felimazole® Tablets, for treating feline hyperthyroidism and Equipalazone®, the market-leading anti-inflammatory and analgesic for equine musculoskeletal disorders. The recent additions of the SPECIFIC® dog and cat diet range, the ophthalmic product Fucithalmic® Vet and the dermatology brands Canaural®, Fuciderm® Gel and Malaseb® Shampoo further strengthen Dechra's product portfolio.

There is a strong emphasis on product development with an ongoing programme of investment that will enhance our product offering to veterinarians across Europe

SPECIFIC® Diets The complete diet programme for every phase of a cat's or dog's life. Visit website	Vetoryl® Now offered in new blister packs containing 30 capsules. Click here for more	Felimazole® For the treatment of feline hyperthyroidism. Click here for more